OptiScanner 5000 Glucose Monitoring System— 510(k) K162042

Substantially Equivalent

Optiscan Biomedical Corp.

FDA 510(k) clearance K162042 for OptiScanner 5000 Glucose Monitoring System, Substantially Equivalent on 2017-10-16. Applicant: Optiscan Biomedical Corp..

Clearance details

Applicant: Optiscan Biomedical Corp.
Product code: Code LZF
Advisory panel: General Hospital
Date received: 2016-07-25
Decision date: 2017-10-16
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Hayward, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.